Plasma adiponectin is related to other cardiovascular risk factors in nondiabetic Korean men with CAD, independent of adiposity and cigarette smoking: Cross-sectional analysis

Clinica Chimica Acta

Volumn 370, Issue 1-2, 2006, Pages 63-71

  Kim, Oh Yoen ^a   Koh, Soo Jeong ^a   Jang, Yangsoo ^a,b   Chae, Jey Sook ^d   Kim, Ji Young ^a,c   Kim, Hyae Jin ^a   Cho, Hongkeun ^a   Lee, Jong Ho ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c DNA Link Inc   (South Korea)

^d DNA link Ltd ^*

Author keywords

Adiponectin; Cardiovascular risk adiposity; Cigarette smoking; Coronary artery disease

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DRINKING BEHAVIOR; HUMAN; INSULIN RESISTANCE; KOREA; MAJOR CLINICAL STUDY; MALE; OBESITY; PARTICLE SIZE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOSITY; ADULT; AGED; ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HUMANS; INSULIN RESISTANCE; KOREA; LIPID METABOLISM; MALE; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 33746220437     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.01.021     Document Type: Article

References (54)

1. Matsuzawa Y., Funahashi T., Kihara S., and Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 (2004) 29-33
2. Ryo M., Nakamura T., Kihara S., et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 68 (2004) 975-981
3. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., and Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14 (2003) 561-566
4. Berg A.H., Combs T.P., and Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13 (2003) 84-89
5. Tsao T.S., Lodish H.F., and Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 440 (2002) 213-221
6. Engeli S., Feldpausch M., Gorzelniak K., et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 52 (2003) 942-947
7. Ouchi N., Kihara S., Arita Y., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
8. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
9. Nemet D., Wang P., Funahashi T., et al. Adipocytokines, body composition, and fitness in children. Pediatr Res 53 (2003) 148-152
10. Matsubara M., Namioka K., and Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol 148 (2003) 657-662
11. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 203;107:671-4.
12. Maruyoshi H., Kojima S., Otsuka F., et al. Hypoadiponectinemia is associated with coronary artery spasm in men. Circ J 69 (2005) 1154-1156
13. Dzielinska Z., Januszewicz A., Wiecek A., et al. Decreased plasma concentration of a novel anti-inflammatory protein-adiponectin-in hypertensive men with coronary artery disease. Thromb Res 110 (2003) 365-369
14. Nakamura Y., Shimada K., Fukuda D., et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 90 (2004) 528-533
15. Maruyoshi H., Kojima S., Funahashi T., et al. Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina. Thromb Haemost 91 (2004) 1026-1030
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and complications of diabetes mellitus. Diabetes Care 1 (1997) 1183-1197
17. The Am Dietetic Asso. Handbook of clinical dietetics. 2nd ed. (1992), Yale Univ Press, MA 5-39
18. Christian J.L., and Greger J.H. Nutrition for living (1991), The Benjamin/Cummings Publ. Comp. Inc., C.A. 111
19. Moshides J.S. Kinetic enzymatic method for automated determination of HDL cholesterol in plasma. J Clin Chem Clin Biochem 25 (1987) 583-587
20. Friedewald W.T., Levy R.T., and Frederickson D.S. Estimatin of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 18 (1972) 449-502
21. Haffner S.M., Kennedv E., Gonsalez C., et al. A prospective analysis of the HOMA model. Diabetes Care 19 (1996) 1138-1141
22. Jang Y., Lee J.H., Chae J.S., et al. Association of the 276G→T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am J Clin Nutr 82 (2005) 760-767
23. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
24. Spranger J., Kroke A., Mohlig M., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361 (2003) 226-228
25. Lindsay R.S., Funahashi T., Hanson R.L., et al. Adiponectin and development of type 2 diabetes in the Pima India population. Lancet 360 (2002) 57-58
26. Chan K.C., Chou H.H., Wu D.J., Wu Y.L., and Huang C.N. Diabetes mellitus has an additional effect on coronary artery disease to decrease plasma adiponectin levels. Jpn Heart J 45 (2004) 921-927
27. Iwashima Y., Katsuya T., Ishikawa K., et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension 45 (2005) 1094-1100
28. Thamer C., Stefan N., Stumvoll M., Haring H., and Fritsche A. Reduced adiponectin serum levels in smokers. Atherosclerosis 179 (2005) 412-422
29. Fernadez-Real J.M., Broch M., Vendrell J., and Ricart W. Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway. Int J Obes Relat Disord 27 (2003) 1552-1556
30. Kern P.A., Di Gregorio G.B., Lu T., Rassouli N., and Ranganatha G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis-factor alpha expression. Diabetes 52 (2003) 1779-1785
31. Stejskai D., Ruezicka V., Fanfrdlova G., Kolar V., and Bartek J. High adiponectin and TNF-α levels in moderate drinkers suffering from liver steatosis: comparison with non-drinkers suffering from similar hepatopathy. Biomed Pap 149 (2005) 93-99
32. Pischon T., Girman C., Rifai N., Hotamisligil G.S., and Rim E.B. Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr 81 (2005) 780-786
33. Sierksma A., Patel H., Kihara S., et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-α, and insulin sensitivity. Diabetes Care 27 (2005) 184-189
34. Hulthe J., Hulten L.M., and Fagerberg B. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism 52 (2003) 1612-1614
35. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
36. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverse insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001) 941-946
37. Maeda N., Takahashi M., Funahashi T., et al. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 (2001) 2094-2099
38. Yang W.S., Jeng C.Y., Wu T.J., et al. Synthetic peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 25 (2002) 376-380
39. Hirose H., Kawai T., Yamamoto Y., et al. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism 51 (2002) 314-317
40. Yang W.S., Lee W.J., Funahashi T., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001) 3815-3819
41. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., and Okamoto Y. plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Aarterioscler Thromb Vasc Biol 20 (2000) 1596-1599
42. Matsubara M., Maruoka S., and Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocriol Metab 82 (2002) 2764-2769
43. Wulster-Radcliffe M.C., Ajuwon K.M., Wang J., Christian J.A., and Spurlock M.E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 316 (2004) 924-929
44. Yokota T., Oritani K., Takahashi I., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000) 1723-1732
45. Calabro P., Willerson J.T., and Yeh E.T. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108 (2003) 1930-1932
46. Galve-de Rochemonteix B., Wiktorowicz K., Kushner I., and Dayer J.M. C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages. J Leukoc Biol 53 (1993) 439-445
47. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
48. Matsuzawa Y., Funahashi T., and Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 892 (1999) 46-154
49. Gould J.M., and Weiser J.N. Expression of C-reactive protein in the human respiratory tract. Infect Immun 69 (2001) 1747-1754
50. Bastard J.P., Jardel C., Delattre J., Hainque B., Bruckert E., and Oberlin F. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 99 (1999) 2221-2222
51. Ballou S.P., and Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4 (1999) 361-368
52. Nakagomi A., Freedman S.B., and Geczy C.L. Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Circulation 101 (2000) 1785-1791
53. Okamoto Y., Arita Y., Nishida M., et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular wall. Horm Metab Res 32 (2000) 47-50
54. Kumada M., Kihara S., Sumitsuji S., et al. Coronary artery disease association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89